Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). I. Isolation and characterization
- PMID: 3917468
Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). I. Isolation and characterization
Abstract
A lymphokine inhibitory for cellular DNA synthesis (termed STIF) was isolated from the culture supernatants of concanavalin A (Con A)-stimulated SD rat spleen cells. STIF inhibited the DNA synthesis of mouse bone marrow cells as well as mouse leukemia cells. STIF has an apparent m.w. of 45,000 to 50,000 and is separable from IL 2, m.w. 20,000 to 25,000, by Sephacryl S-200 gel filtration, but not from immune interferon (IFN) having the same m.w. as STIF. Con A-Sepharose chromatography of the fraction containing STIF and IFN could separate these lymphokines into Con A-unbound and Con A-bound fractions, respectively. Further fractionation of the STIF fraction by DEAE-Sephadex A-50 or Mono Q-FPLC anion exchange chromatography indicated that the STIF fraction contained two components of STIF activity, both showing the same pI value (5.1 to 5.6) on flat-bed isoelectric focusing. STIF was characterized as a sugar-free lymphokine of trypsin-sensitive protein nature.
Similar articles
-
Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.J Immunol. 1985 May;134(5):3172-8. J Immunol. 1985. PMID: 2580017
-
Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). II. Kinetics of the production and characterization of the producer.J Immunol. 1985 Feb;134(2):1026-31. J Immunol. 1985. PMID: 2578147
-
A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).J Immunol. 1984 Dec;133(6):3084-90. J Immunol. 1984. PMID: 6238094
-
Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.J Immunol. 1983 Oct;131(4):1854-9. J Immunol. 1983. PMID: 6352807
-
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.J Immunol. 1980 Apr;124(4):1954-62. J Immunol. 1980. PMID: 6444967
Cited by
-
Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2.Cancer Immunol Immunother. 1986;21(1):12-8. doi: 10.1007/BF00199371. Cancer Immunol Immunother. 1986. PMID: 3484674 Free PMC article.
-
Roles of IL-2 and antigen in the later stages of the primary antibody response.Immunology. 1987 Oct;62(2):199-205. Immunology. 1987. PMID: 3315978 Free PMC article.
-
A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.J Exp Med. 1986 Jan 1;163(1):18-40. doi: 10.1084/jem.163.1.18. J Exp Med. 1986. PMID: 2416868 Free PMC article.
-
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.Br J Cancer. 1992 Jul;66(1):20-6. doi: 10.1038/bjc.1992.210. Br J Cancer. 1992. PMID: 1353365 Free PMC article.
-
Suppressin: an endogenous negative regulator of immune cell activation.Immunol Res. 1994;13(1):1-9. doi: 10.1007/BF02918219. Immunol Res. 1994. PMID: 7897257 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous